RGEN Q1 2021 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q1 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$143M+87.7% YoY

Gross Profit

$83M58.2% margin

Operating Income

$36M25.5% margin

Net Income

$29M20.6% margin

EPS (Diluted)

$0.52

QoQ Revenue Growth

+31.5%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$194,000

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$371M

Stockholders' Equity

$1.6B

Cash & Equivalents

$711M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$143M	$76M	+87.7%
Gross Profit	$83M	$44M	+88.4%
Operating Income	$36M	$12M	+205.6%
Net Income	$29M	$10M	+200.1%

Revenue Segments

Product

$143M100%

Royalty

$100,0000%